Alliance
C4U and Logomix have entered into the joint research agreement on applying CRISPR-Cas3 genome editing technology to Logomix’s Geno-WritingTM technology.
C4U and Logomix have entered into the joint research agreement on applying CRISPR-Cas3 genome editing technology to Logomix’s Geno-WritingTM technology.